EPI — Epiminder Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Epiminder Limited is an Australia-based medical device and information solutions company, which is focused on developing diagnostic and treatment tools for epilepsy and other seizure disorders where continuous monitoring is required. The Minder system is a minimally invasive device with equivalent form factors to a cochlear hearing device. The Minder Implant is a device placed under the scalp with several electrodes placed under the scalp, across the back of the head-this enables bilateral monitoring. Minder Wearable receives and stores EEG recordings wirelessly transmitted from the Minder Implant, then transfers this data wirelessly via low-power Bluetooth to the Minder App, running on a smartphone. The Minder App collects and transmits EEG data from the Minder Wearable via Bluetooth and uploads it to Minder Cloud for secure storage and processing. Minder Cloud offers a secure online portal that allows healthcare professionals to access and download patient data for viewing.
Directors
- Last Annual
- Last Interim
- Incorporated
- January 16th, 2017
- Public Since
- December 1st, 2025
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Address
- MELBOURNE, 3000
- Web
- https://epiminder.com/
- Phone
- Auditors
Similar to EPI
4DMedical
Australian Stock Exchange - SEATS
Adheris Health
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:30 UTC, shares in Epiminder are trading at AU$1.01. This share price information is delayed by 15 minutes.
Shares in Epiminder last closed at AU$1.01 and the price had moved by over the past 365 days. In terms of relative price strength the Epiminder share price has matched the ASX All Ordinaries Index by over the past year.
There is no consensus recommendation for this security.
Find out moreEpiminder does not currently pay a dividend.
Epiminder does not currently pay a dividend.
Epiminder does not currently pay a dividend.
To buy shares in Epiminder you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$1.01, shares in Epiminder had a market capitalisation of .
Here are the trading details for Epiminder:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EPI
Based on an overall assessment of its quality, value and momentum Epiminder is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Epiminder. Over the past six months, its share price has matched the ASX All Ordinaries Index by .
As of the last closing price of AU$1.01, shares in Epiminder were trading -13.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Epiminder PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$1.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Epiminder's directors